SOPROCAL Stock Overview
Manufactures and sells calcium carbonate, lime, and other mineral derivatives in Chile. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Soprocal, Calerías e Industrias S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CL$270.50 |
| 52 Week High | CL$290.00 |
| 52 Week Low | CL$290.00 |
| Beta | -0.00035 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | 0% |
| 5 Year Change | 0.19% |
| Change since IPO | -11.31% |
Recent News & Updates
Shareholder Returns
| SOPROCAL | CL Basic Materials | CL Market | |
|---|---|---|---|
| 7D | 0% | 0.01% | -0.4% |
| 1Y | 0% | 4.6% | 10.4% |
Return vs Industry: SOPROCAL underperformed the CL Basic Materials industry which returned 4.6% over the past year.
Return vs Market: SOPROCAL underperformed the CL Market which returned 10.4% over the past year.
Price Volatility
| SOPROCAL volatility | |
|---|---|
| SOPROCAL Average Weekly Movement | 0% |
| Basic Materials Industry Average Movement | 4.3% |
| Market Average Movement | 2.1% |
| 10% most volatile stocks in CL Market | 3.5% |
| 10% least volatile stocks in CL Market | 0.5% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine SOPROCAL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1940 | 69 | Ricardo Thiers | www.soprocal.cl |
Soprocal, Calerías e Industrias S.A. manufactures and sells calcium carbonate, lime, and other mineral derivatives in Chile. It serves various sectors, such as construction, mining, agriculture, and environment sectors. The company was founded in 1940 and is based in Santiago, Chile.
Soprocal, Calerías e Industrias S.A. Fundamentals Summary
| SOPROCAL fundamental statistics | |
|---|---|
| Market cap | CL$2.66b |
| Earnings (TTM) | -CL$1.51b |
| Revenue (TTM) | CL$11.57b |
0.2x
P/S Ratio-1.8x
P/E RatioIs SOPROCAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOPROCAL income statement (TTM) | |
|---|---|
| Revenue | CL$11.57b |
| Cost of Revenue | CL$10.09b |
| Gross Profit | CL$1.48b |
| Other Expenses | CL$2.99b |
| Earnings | -CL$1.51b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -153.20 |
| Gross Margin | 12.79% |
| Net Profit Margin | -13.04% |
| Debt/Equity Ratio | 5.0% |
How did SOPROCAL perform over the long term?
See historical performance and comparison